ELUCIREM sol inj 15 ml flacon

7680690370046 CH-69037 V08CA12 14.02.0.

Active substances:

No images available

Details

Product number
6903701
CPT
-
Packaging group
15
Unit
ml
Composition
gadopiclenolum 485.1 mg corresp. 0.5 mmol corresp. gadolinium 78.6 mg, tetraxetanum, trometamolum, natrii hydroxidum aut acidum hydrochloridum ad pH, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 0.46 mg.

Articles (1)

Elucirem 0.5 mmol/ml, Injektionslösung in einer Durchstechflasche
Injektionslösung
15
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
gadopiclenolum
485.1 MG Substance Wirkstoff (Principe actif)
gadolinium
78.6 MG Substance WIIS
tetraxetanum
- Substance HNIDK
trometamolum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
acidum hydrochloridum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
0.46 MG Substance HBESI

Authorization holder

Guerbet AG

8050 Zürich

Authorization information

Swissmedic authorization number
69037
Drug name
Elucirem, Injektionslösung in einer Durchstechflasche
Galenic form
LSINJ
ATC Code
V08CA12
Authorization status
Z
Dispensation category
B
First authorization
21/12/2023
Authorization expiration date
20/12/2028
IT number
14.02.0.
Domain
Human medicine
Field of application
MRT-Kontrastmittel für die ZNS-Diagnostik und weitere Körperregionen

Packaging details

Description (FR)
ELUCIREM sol inj 15 ml flacon
Description (DE)
ELUCIREM Inj Lös; 15 ml Durchstechflasche
Market launch
21/12/2023
Market withdrawal
20/12/2028
Narcotic (BTM)
No

Other packaging sizes

ELUCIREM sol inj; 3 ml flacon
3 ML
View
ELUCIREM sol inj; 7.5 ml Flacon
7.5 ML
View
ELUCIREM sol inj; 10 ml Flacon
10 ML
View
ELUCIREM sol inj; 30 ml Flacon
30 ML
View
Buy us a coffee Explore the data